Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination

Title
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination
Authors
Keywords
NCT01823536, Meningococcal vaccine, Childhood vaccination, Antibody persistence, Booster vaccination
Journal
VACCINE
Volume 33, Issue 18, Pages 2175-2182
Publisher
Elsevier BV
Online
2015-03-02
DOI
10.1016/j.vaccine.2015.02.049

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started